Search clinical trials for: Hormone Antagonists
Total 38607 results
-
University Health Network, TorontoActive, not recruitingBreast Cancer | Advanced Solid CancersCanada
-
GlaxoSmithKlineTerminatedNeoplasmsUnited States, Korea, Republic of, Canada, Spain, Australia, United Kingdom, France
-
Velindre NHS TrustAstraZeneca; Cardiff and Vale University Health Board; Covance; Cenduit LLCActive, not recruitingEstrogen Receptor Positive Breast CancerUnited Kingdom
-
Fudan UniversityActive, not recruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Mayo ClinicAstraZeneca; National Institutes of Health (NIH)CompletedHealthyUnited States
-
AstraZenecaCompletedPuberty, Precocious | McCune-Albright SyndromeItaly, United States, Germany, France, Russian Federation, United Kingdom
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Metastatic Breast Cancer | Breast Cancer Stage IV | Solid Carcinoma | HER2-negative Breast Cancer | MEK1 Gene Mutation | MEK2 Gene MutationUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Prostate Cancer | Advanced Solid TumorsUnited States
-
Eli Lilly and CompanyCompleted
-
Hoffmann-La RocheTerminatedEstrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast CancerCanada, United States, United Kingdom, Australia, Germany
-
University of PennsylvaniaCompletedPulmonary Arterial HypertensionUnited States
-
Sun Yat-sen UniversityAstraZenecaUnknown
-
Fresenius KabiCompleted
-
Isabel BlancasCompletedMalignant Neoplasm of Breast Stage IVSpain
-
King Abdullah International Medical Research CenterRecruitingModerate Covid19Saudi Arabia
-
New Valley UniversityCompletedProgesterone Primed Endometrial Protocol | Gonadotropin Releasing Hormone Antagonist Protocol | Assisted Reproductive TreatmentsEgypt
-
University of California, Los AngelesOregon Health and Science UniversityCompletedPolycystic Ovary Syndrome (PCOS)United States
-
Federal University of Minas GeraisCompletedFlow-mediated Dilation Evaluation of the Brachial ArteryBrazil
-
M.D. Anderson Cancer CenterNot yet recruitingHormone Receptor-positive Human Epidermal Growth Factor 2-negative | Metastatic Invasive LObular CarcinomaUnited States
-
Institut Paoli-CalmettesMerck KGaA, Darmstadt, Germany; National Cancer Institute, FranceNot yet recruiting
-
Tianjin Medical University Cancer Institute and...Not yet recruiting
-
University of Colorado, DenverUnited States Department of DefenseActive, not recruitingBreast CancerUnited States
-
Eli Lilly and CompanyActive, not recruitingNeoplasm Metastasis | Breast NeoplasmUnited States, Hungary, Italy, Czechia, Taiwan, Turkey, Belgium, Spain, Korea, Republic of, Israel, Argentina, Greece, France, Mexico, Sweden, Denmark, Poland
-
Kashiv BioSciences, LLCCompletedMetastatic Breast CancerJordan
-
Betta Pharmaceuticals Co., Ltd.Active, not recruiting
-
Nuvation Bio Inc.WithdrawnBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Breast Carcinoma | Cancer of Breast | Malignant Tumor of Breast | Breast Tumor | Cancer of the BreastUnited States
-
Memorial Sloan Kettering Cancer CenterDebiopharm International SACompletedBreast CancerUnited States
-
Roswell Park Cancer InstituteTerminated
-
Stanford UniversityAstraZenecaCompletedProstatic Neoplasms | Prostate CancerUnited States
-
AstraZenecaCompleted
-
The Center for Rheumatic Disease, Allergy, & ImmunologyAstraZenecaCompletedSystemic Lupus ErythematosusUnited States
-
AstraZenecaCompletedBreast CancerUnited States, Brazil, United Kingdom, Germany, Austria, India
-
Zhejiang Cancer HospitalRecruitingBreast Neoplasm FemaleChina
-
Novartis PharmaceuticalsActive, not recruiting
-
Dana-Farber Cancer InstitutePuma Biotechnology, Inc.Terminated
-
Henan Cancer HospitalActive, not recruitingMetastatic Breast CancerChina
-
European Organisation for Research and Treatment...Breast International GroupTerminatedBreast CancerUnited Kingdom
-
SanofiTerminatedBreast NeoplasmsFrance, Italy, Spain
-
Nanjing Chia-tai Tianqing PharmaceuticalRecruitingHR Positive/HER-2 Negative Breast CancerChina
-
Scorpion Therapeutics, Inc.RecruitingBreast Cancer | Gynecologic Cancer | HNSCC | Solid Tumors, AdultUnited States, Spain, France, Italy
-
Liaoning Tumor Hospital & InstituteNot yet recruiting
-
The First Affiliated Hospital of Zhengzhou UniversityRecruitingBreast Cancer | Breast Cancer FemaleChina
-
Novartis PharmaceuticalsRecruiting
-
Sun Yat-sen UniversityRecruiting
-
Eli Lilly and CompanyActive, not recruitingBreast NeoplasmsUnited States, Spain, Germany, Taiwan, Canada, Japan, Australia, Belgium, Denmark, France, Finland, Mexico, Italy, Korea, Republic of, Poland, Russian Federation, Switzerland, Puerto Rico, Romania, Greece
-
Novartis PharmaceuticalsActive, not recruiting
-
PfizerWithdrawnBreast Cancer | Ovarian Cancer | Non-small Cell Lung Cancer (NSCLC) | Solid Tumors | Liposarcoma | Endometrial